SL
CRNX

Siren LLC’s Crinetics Pharmaceuticals CRNX Stock Holding History

Siren LLC’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.2M Sell
1,420,788
-482,848
-25% -$17.9M 1.08% 30
2026
Q1 		$69.1M Buy
1,903,636
+396,000
+26% +$17.7M 1.92% 13
2025
Q4 		$70.2M Sell
1,507,636
-180,975
-11% -$8.06M 2.09% 15
2025
Q3 		$70.3M Hold
1,688,611
– – 2.75% 7
2025
Q2 		$48.6M Hold
1,688,611
– – 2.51% 5
2025
Q1 		$56.6M Buy
1,688,611
+78,959
+5% +$2.95M 3.19% 5
2024
Q4 		$82.3M Buy
1,609,652
+300,000
+23% +$16.8M 3.64% 5
2024
Q3 		$66.9M Buy
+1,309,652
New +$67.5M 3.35% 6

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Siren LLC's CRNX Position: Q2 2026 in Review

Siren LLC reduced its Crinetics Pharmaceuticals (CRNX) stake by 25% in Q2 2026, selling an estimated $17.9M and leaving 1,420,788 shares worth $53.2M. The position accounts for 1.08% of the portfolio, ranked #30.

Siren LLC first reported a position in CRNX in Q3 2024 and has held it in 8 quarters since. The position peaked at $82.3M in Q4 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Siren LLC held 1,420,788 shares of Crinetics Pharmaceuticals worth $53.2M as of Q2 2026.
  • Siren LLC sold 482,848 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $17.9M.
  • Crinetics Pharmaceuticals made up 1.08% of Siren LLC's portfolio in Q2 2026, its #30 holding.
  • Siren LLC first reported a position in Crinetics Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Siren LLC's Crinetics Pharmaceuticals position peaked at $82.3M in Q4 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.